Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
October 21, 2022 at 11:00 AM EDT
More NewsView More
Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why
Today 9:38 EDT
DoorDash Buys Deliveroo: A Game Changer?
Today 7:34 EDT
Clearway Energy’s Price Dip: 3 Reasons It’s a Signal to Buy
Today 7:15 EDT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
